MedTech
Springboard welcomes Alex Vasiev in his new role
Springboard Pro, a leading engineering consultancy company based in Cambridge, UK, is pleased to announce the addition of Alex Vasiev to the team as a business development manager and engineer. With a wealth of experience and expertise in device development, Alex is set to bring valuabl...
Outside the box: scale up your ambitions with a Guardtech Cleanrooms modular
The Guardtech Group’s modular champions are offering flexible solutions that grow and adapt alongside their clients’ aspirations. ...
Introduction to Drug Development – From Candidate Selection to Patients in Healthcare
Audience Those who want to understand what is done to bring new treatments to patients, and/or better operate with the language of internal customers. Typically people in non life-science technical roles in our sector – IT, Finance, HR and Admin staff. Also helpful for e...
IP Corner: Commercialising your IP in China
Your IP in China, apart from protecting it, you can also capitalise on it. Is there value in commercialising their intellectual properties in China for UK businesses? How do you go about it? Take a look at the driving forces behind China’s commercial IP market and you may find the clue....
FirstStage - a VR creative toolkit
The FirstStage VR toolkit is a collaborative virtual production tool that is applicable across multiple industries. ...
Undiagnosed breathing conditions could cause winter NHS crisis
electronRx writes...
Guardtech Group: the growing family business with global aspirations
Cleanroom construction specialists determined to retain their family values as individual brands continue to thrive in UK and beyond ...
Cresset shares September 2023 news
Welcome to the September Cresset Newsletter Optimize your decision-making across the entire design-make-test-analyze (DMTA) cycle with this month's collection of CADD software features, expert scientific opinion, and first-class drug discovery research resources. You can subscrib...
Streamline sharing of CADD data seamlessly to accelerate your drug design process
Introduction The globalized outsourcing model of modern drug discovery is driving efficiencies across the Design-Make-Test-Analyze (DMTA) cycle. With projects typically involving multiple specialist CROs, effective communication is key to ensuring the success of these collaborations. ...